% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • kvnmccdd kvnmccdd Apr 1, 2013 4:46 PM Flag

    Insmed Appoints Matthew Pauls as Chief Commercial Officer

    Insmed Appoints Matthew Pauls as Chief Commercial Officer

    20-Year Industry Veteran Brings Global Sales, Marketing and Reimbursement Expertise From Leading Pharmaceutical Companies

    MONMOUTH JUNCTION, NJ -- (Marketwire) -- 04/01/13 -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases in orphan indications that are often life-threatening, announces the appointment of Matthew Pauls as Chief Commercial Officer. In this newly created position, Mr. Pauls reports to Will Lewis, President and Chief Executive Officer, and has full global commercial responsibility for ARIKACE®, liposomal amikacin for inhalation, which is under development to treat Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients and patients with non-tuberculous mycobacteria (NTM) lung infections.

    The Sbashers are slowly dying now.......soon very soon!

    Until Then!

    Sentiment: Strong Buy

13.22+0.32(+2.48%)Aug 26 4:00 PMEDT